<DOC>
	<DOCNO>NCT01017172</DOCNO>
	<brief_summary>The purpose study evaluate immunogenicity safety adjuvanted A ( H1N1 ) v influenza vaccine HIV-infected immunosuppressed patient one two injection .</brief_summary>
	<brief_title>Safety Immune Response Adjuvanted A ( H1N1 ) v Influenza Vaccine HIV-1 Infected Immunosuppressed Adult Patients</brief_title>
	<detailed_description>The efficacy adjuvanted A ( H1N1 ) v influenza vaccine HIV-infected immunosuppressed patient unknown . Therefore aim investigate immunoresponse assess anti-hemagglutinin assay , 21 day first 21 day second vaccination . The safety vaccination record standardized questionaire .</detailed_description>
	<criteria>write informed consent age &gt; 18 HIV1 infection cancer immunosuppressive treatment willing participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>